Trust & Policies
Compliance Policy
Last updated: June 18, 2026
RIVACTA reviews advertising expression, consumer protection, privacy, and anti-social-forces exclusion under Japanese law. This is general guidance. Specific matters require professional confirmation.
This page describes the policies of RIVACTA (operated by BCROSSB Inc.). The specific rights and obligations of any engagement are governed by the signed written agreement between the parties.
1. Scope
We review under the Act on the Protection of Personal Information, the Act against Unjustifiable Premiums and Misleading Representations, the Act on Specified Commercial Transactions, medical advertising guidelines, industry licensing/labeling rules, ad-platform policies, and anti-social-forces exclusion.
2. Fair representation (Premiums & Representations Act)
In line with the prohibition on representations that mislead consumers into thinking quality or price is markedly superior or more favorable than reality, we review client ads, landing pages, and content for misleading superiority/advantage claims.
3. Mail-order (Specified Commercial Transactions Act)
We consider advertising display, the ban on exaggerated ads, the ban on email ads to non-consenting recipients, and the requirement that a final confirmation screen lets consumers review and correct their order.
4. Medical advertising
For medical/beauty, under the Medical Care Act and medical advertising guidelines, we separately review claims of guaranteed efficacy, comparative superiority, before/after imagery, testimonials, and risk disclosure. Final responsibility rests with the client.
5. Privacy
Collection, use, third-party provision, and AI processing follow the Privacy Policy. Reference checks are based on consent and a clear purpose.
6. Anti-social-forces exclusion
RIVACTA includes an anti-social-forces (organized-crime) exclusion clause in contracts and does not accept businesses with possible ties.